Clinical data of 55 patients with DLBCL with aberrant coexpression of CD10, BCL6, and MUM1
| Parameter . | No. of cases . |
|---|---|
| Age | Mean 70 y (range 37-92 y) |
| Male gender | 22 (40%) |
| Female gender | 33 (60%) |
| Stage I/II | 19/45 (42%) |
| Stage III/IV | 26/45 (58%) |
| Localization | |
| Nodal presentation | 23 cases (42%) |
| Extranodal presentation | 32 cases (58%) |
| Tonsil/Waldeyeŕs ring | 10 cases (18%) |
| Gastrointestinal tract | 6 cases (11%) |
| Testis | 3 cases (5%) |
| Breast | 2 cases (4%) |
| Other | 11 cases (20%) |
| Alive, no evidence of disease | 30/48 patients (62%) |
| Median follow-up (range) | 36 mo (7-97 mo) |
| Died of disease | 9/48 patients (19%) |
| Median (range) | 7 mo (1-21 mo) |
| Cell of origin | |
| GCB | 32/54 (59%) |
| ABC | 16/54 (30%) |
| UC | 6/54 (11%) |
| Parameter . | No. of cases . |
|---|---|
| Age | Mean 70 y (range 37-92 y) |
| Male gender | 22 (40%) |
| Female gender | 33 (60%) |
| Stage I/II | 19/45 (42%) |
| Stage III/IV | 26/45 (58%) |
| Localization | |
| Nodal presentation | 23 cases (42%) |
| Extranodal presentation | 32 cases (58%) |
| Tonsil/Waldeyeŕs ring | 10 cases (18%) |
| Gastrointestinal tract | 6 cases (11%) |
| Testis | 3 cases (5%) |
| Breast | 2 cases (4%) |
| Other | 11 cases (20%) |
| Alive, no evidence of disease | 30/48 patients (62%) |
| Median follow-up (range) | 36 mo (7-97 mo) |
| Died of disease | 9/48 patients (19%) |
| Median (range) | 7 mo (1-21 mo) |
| Cell of origin | |
| GCB | 32/54 (59%) |
| ABC | 16/54 (30%) |
| UC | 6/54 (11%) |
UC, unclassifiable.